Novel Thrombolytic Drug Based on Thrombin Cleavable Microplasminogen Coupled to a Single-Chain Antibody Specific for Activated GPIIb/IIIa.

about

Development and validation of a high throughput whole blood thrombolysis plate assay.

P2860

Q33725847-8A37F180-36A7-468C-B6F5-32DBE062E6F6

P2860

Novel Thrombolytic Drug Based on Thrombin Cleavable Microplasminogen Coupled to a Single-Chain Antibody Specific for Activated GPIIb/IIIa.

Item

http://www.wikidata.org/entity/Q41102431

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Novel Thrombolytic Drug Based ...... ific for Activated GPIIb/IIIa.

@en

type

Item

label

Novel Thrombolytic Drug Based ...... ific for Activated GPIIb/IIIa.

@en

prefLabel

Novel Thrombolytic Drug Based ...... ific for Activated GPIIb/IIIa.

@en

P1476

Novel Thrombolytic Drug Based ...... ific for Activated GPIIb/IIIa.

@en

P2093

Lok Soon Law

http://www.w3.org/2001/XMLSchema#string

Robert Lindsay Medcalf

http://www.w3.org/2001/XMLSchema#string

Ruchi Kanojia

http://www.w3.org/2001/XMLSchema#string

Sheena Rigby

http://www.w3.org/2001/XMLSchema#string

Shweta Jagdale

http://www.w3.org/2001/XMLSchema#string

Zachary Tennant

http://www.w3.org/2001/XMLSchema#string

P2860

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Thrombolytic therapy for pulmonary embolism

A chimeric platelet-targeted urokinase prodrug selectively blocks new thrombus formation

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

A fibrin-specific thrombolytic nanomedicine approach to acute ischemic stroke

Fibrinolytic therapy in acute stroke.

Single-chain antibodies for the conformation-specific blockade of activated platelet integrin alphaIIbbeta3 designed by subtractive selection from naive human phage libraries.

Molecular recognition mechanisms of thrombin.

Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets.

Composition of coronary thrombus in acute myocardial infarction.

P31

scholarly article

P356

10.1161/JAHA.116.004535

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christoph E. Hagemeyer

P577

2017-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28159824

http://www.w3.org/2001/XMLSchema#string

P921

thrombolysis

P932

5523756

http://www.w3.org/2001/XMLSchema#string

Novel Thrombolytic Drug Based on Thrombin Cleavable Microplasminogen Coupled to a Single-Chain Antibody Specific for Activated GPIIb/IIIa.

about

P2860

P2860

Novel Thrombolytic Drug Based on Thrombin Cleavable Microplasminogen Coupled to a Single-Chain Antibody Specific for Activated GPIIb/IIIa.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P921

P932